First-in-Class Precision Medicines for EBV-Driven Autoimmune Diseases
EBVio is a preclinical therapeutics company developing novel treatments targeting the root cause of major autoimmune diseases
EBVio is a preclinical therapeutics company developing novel treatments targeting the root cause of major autoimmune diseases
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.